Efinopegdutide is a promising biomedicine designed to target the treatment of obesity and type 2 diabetes. Through its potent agonist activity on the glucagon-like peptide 1 receptor, it promotes weight loss by reducing appetite and increasing feelings of fullness. Additionally, Efinopegdutide improves glycemic control by regulating insulin secretion and glucose metabolism.
CAT# | R2023 |
CAS | 2055640-93-0 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Figure 1. Chemical structure of pentagastrinPentagastrin, known as peptavlon, is a synthetic pentapeptide that p ...
The hexapeptide-9, a cosmetic peptide of skin agingSkin aging is the obvious external manifestation of a natural ...
Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
Delmitide, also known as RDP58, is a novel D-amino acid decapeptide with anti-inflammatory effect. RDP58 is a te ...